Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB)

CUSIP: 005111109

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
60,359,615
Total 13F shares
8,589,440
Share change
-563,373
Total reported value
$5,982,496
Price per share
$0.70
Number of holders
28
Value change
-$427,073
Number of buys
10
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 005111109?
CUSIP 005111109 identifies AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ORBIMED ADVISORS LLC
3/4/5 13F
Director, 10%+ Owner · Company
4.4%
from 13F
1,677,361
$2,616,683 19 Jul 2021
Shahzad Malik
3/4/5
Director
mixed-class rows
1,562,757
mixed-class rows
$2,426,946 17 Jun 2021
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
4.4%
2,660,808
$2,362,798 30 Jun 2023
13F
VANGUARD GROUP INC
13F
Company
1.9%
1,140,706
$1,012,947 30 Jun 2023
13F
Parkman Healthcare Partners LLC
13F
Company
1.3%
762,025
$676,678 30 Jun 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.61%
369,900
$328,000 30 Jun 2023
13F
AMERICAN FINANCIAL GROUP INC
13F
Company
0.5%
299,995
$266,000 30 Jun 2023
13F
BlackRock Finance, Inc.
13F
Company
0.37%
226,299
$200,954 30 Jun 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.35%
210,563
$186,980 30 Jun 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.3%
182,598
$162,147 30 Jun 2023
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.28%
168,200
$149,360 30 Jun 2023
13F
James F. Hinrichs.
3/4/5
Director
mixed-class rows
95,910
mixed-class rows
$119,043 16 Jun 2022
R. Scott Huennekens
3/4/5
Director
class O/S missing
529,349
$100,047 15 Jun 2023
Vincent J. Burgess
3/4/5
Chief Executive Officer, Director
class O/S missing
61,469
$95,892 01 Apr 2022
Steven McQuillan
3/4/5
SVP, Clinical Affairs & QA
class O/S missing
45,844
$71,517 01 Apr 2022
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.13%
79,500
$70,596 30 Jun 2023
13F
CITADEL ADVISORS LLC
13F
Company
0.12%
73,265
$65,059 30 Jun 2023
13F
Cerity Partners LLC
13F
Company
0.11%
63,698
$56,564 30 Jun 2023
13F
STATE STREET CORP
13F
Company
0.09%
51,871
$46,061 30 Jun 2023
13F
NORTHERN TRUST CORP
13F
Company
0.05%
31,438
$27,917 30 Jun 2023
13F
NICOLET ADVISORY SERVICES, LLC
13F
Company
0.05%
28,484
$25,123 30 Jun 2023
13F
Squarepoint Ops LLC
13F
Company
0.04%
26,361
$23,409 30 Jun 2023
13F
AXXCESS WEALTH MANAGEMENT, LLC
13F
Company
0.04%
25,000
$22,200 30 Jun 2023
13F
Daniella Cramp
3/4/5
Director
mixed-class rows
31,223
mixed-class rows
$18,132 16 Jun 2022
MORGAN STANLEY
13F
Company
0.03%
18,848
$16,737 30 Jun 2023
13F
Charlie Piscitello
3/4/5
SVP, Chief People Officer
class O/S missing
85,683
$16,194 01 Apr 2023
Westside Investment Management, Inc.
13F
Company
0.03%
17,000
$15,096 30 Jun 2023
13F
TWO SIGMA SECURITIES, LLC
13F
Company
0.03%
15,912
$14,130 30 Jun 2023
13F
Tower Research Capital LLC (TRC)
13F
Company
0.02%
12,912
$11,466 30 Jun 2023
13F
FIRST BUSINESS FINANCIAL SERVICES, INC.
13F
Company
0.02%
10,000
$8,880 30 Jun 2023
13F
AdvisorNet Financial, Inc
13F
Company
0.01%
5,625
$4,995 30 Jun 2023
13F
S.A. Mason LLC
13F
Company
0.01%
6,400
$4,826 30 Jun 2023
13F
John F. Sheridan
3/4/5
Director
class O/S missing
24,347
$4,602 15 Jun 2023
WELLS FARGO & COMPANY/MN
13F
Company
0.01%
4,844
$4,302 30 Jun 2023
13F
Jason K. Garland
3/4/5
Director
class O/S missing
22,400
$4,234 15 Jun 2023
Niamh Louise Pellegrini
3/4/5
Director
class O/S missing
20,972
$3,964 15 Jun 2023
Andrew ElBardissi
3/4/5
Director
class O/S missing
20,822
$3,935 15 Jun 2023
David P. Bonita
3/4/5
Director
class O/S missing
20,822
$3,935 15 Jun 2023
Shaden Marzouk
3/4/5
Director
class O/S missing
20,822
$3,935 15 Jun 2023
GROUP ONE TRADING LLC
13F
Company
0.01%
3,404
$3,023 30 Jun 2023
13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
13F
Company
0%
2,725
$2,420 30 Jun 2023
13F
FMR LLC
13F
Company
0%
1,750
$1,554 30 Jun 2023
13F
FEDERATED HERMES, INC.
13F
Company
0%
1,737
$1,542 30 Jun 2023
13F
SIMPLEX TRADING, LLC
13F
Company
0%
1,555
$1,000 30 Jun 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
500
$444 30 Jun 2023
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
254
$226 30 Jun 2023
13F
PNC FINANCIAL SERVICES GROUP, INC.
13F
Company
0%
250
$222 30 Jun 2023
13F

Institutional Holders of Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB) as of Q3 2023

As of 30 Sep 2023, Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,589,440 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), ORBIMED ADVISORS LLC, VANGUARD GROUP INC, Parkman Healthcare Partners LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Schonfeld Strategic Advisors LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 28 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
34
Q3 2023 holders
28
Holder diff
-6
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 Value $ Q3 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .